MUCOPOLYSACCHARIDOSIS TYPE I MARKET: EMERGING TRENDS AND FUTURE PROSPECTS

Mucopolysaccharidosis Type I (MPS I) is a rare genetic condition that interferes with the body's ability to break down glycosaminoglycans (GAGs), leading to their accumulation in organs and tissues. This accumulation results in progressive damage and dysfunction. Common symptoms include developmental delays, organ enlargement, and skeletal deform